Cargando…
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
A cytokine storm drives the pathogenesis of severe COVID-19 infection and several biomarkers have been linked to mortality. Chronic kidney disease (CKD) emerged as a risk factor for severe COVID-19. We investigated the association between selected biomarkers and mortality in 77 patients hospitalized...
Autores principales: | Galassi, Andrea, Ciceri, Paola, Bono, Valeria, Magagnoli, Lorenza, Sala, Matteo, Artioli, Luisa, Rovito, Roberta, Hadla, Mohamad, Yellenki, Vaibhav, D’Arminio Monforte, Antonella, Tincati, Camilla, Cozzolino, Mario, Marchetti, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775159/ https://www.ncbi.nlm.nih.gov/pubmed/36552007 http://dx.doi.org/10.3390/biomedicines10123251 |
Ejemplares similares
-
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
por: Ciceri, Paola, et al.
Publicado: (2022) -
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
por: Rovito, Roberta, et al.
Publicado: (2022) -
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023) -
Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018) -
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19
por: Marchetti, Giulia, et al.
Publicado: (2023)